Adicet Bio Company Insiders

Adicet Bio Management Team Effectiveness

The company has return on total asset (ROA) of (0.3913) % which means that it has lost $0.3913 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.7173) %, meaning that it created substantial loss on money invested by shareholders. Adicet Bio's management efficiency ratios could be used to measure how well Adicet Bio manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to gain to -0.58 in 2026. Return On Capital Employed is likely to gain to -0.69 in 2026. Liabilities And Stockholders Equity is likely to gain to about 213 M in 2026, whereas Total Current Liabilities is likely to drop slightly above 16.6 M in 2026. Common Stock Shares Outstanding is likely to gain to about 106.1 M in 2026The market capitalization of Adicet Bio is $77.28 Million. 30% of Adicet Bio outstanding shares are owned by other corporate entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company. Dividend Yield is likely to gain to 0.000088 in 2026, whereas Dividends Paid is likely to drop slightly above 6.5 M in 2026. Common Stock Shares Outstanding is likely to gain to about 106.1 M in 2026.

Adicet Bio Workforce Comparison

Adicet Bio Insider Trading History

Adicet Bio Notable Stakeholders

String symbol = request.getParameter("s");

The success or failure of an entity such as Adicet Bio often depends on how effective the management is. Adicet Bio management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Adicet management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Adicet management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Please note, the imprecision that can be found in Adicet Bio's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Adicet Bio. Check Adicet Bio's Beneish M Score to see the likelihood of Adicet Bio's management manipulating its earnings.

When running Adicet Bio's price analysis, check to measure Adicet Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Adicet Bio is operating at the current time. Most of Adicet Bio's value examination focuses on studying past and present price action to predict the probability of Adicet Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Adicet Bio's price. Additionally, you may evaluate how the addition of Adicet Bio to your portfolios can decrease your overall portfolio volatility.